The Financial Times reports today that BD (NYSE: BDX) began discussions with competitors for the sale of its Life Sciences ...
In February the company had announced its plan to separate the unit, which consists of biosciences and diagnostic solutions, ...
Becton Dickinson (NYSE:BDX) is in talks with rivals including Thermo Fisher (TMO) and Danaher (DHR) over plans to divest its ...
Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.
Becton, Dickinson and Company (BD) has treated the first subject in the randomised multi-centre STANCE trial with GalaFLEX ...
BD, Medtronic and Abbott were among the top 10 device companies with the highest number of late reports to the FDA, the study found.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” ...